Criterion I
Market capitalization of NT$ 1billion or more.
Operating revenue for the aggregate for the last four quarters is greater than NT$100 million.
A sufficient amount of working capital covering the period of 12 months after the listing.
Criterion II (Limited to Biotech and medical Businesses)
Market capitalization of NT$2 billion or more.
Working capital covering of 125% for the 12 months period after the listing.
A pharmaceutical company’s core product – new drug has to go through Phase I clinical trials.
Criterion III
Market capitalization of NT$4 billion or more.
Working capital covering of 125% for the 12 months period after the listing.